Top Banner

of 34

Individualization of drug dosage regimen.ppt

Jul 07, 2018

Download

Documents

Preethi Iyengar
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/18/2019 Individualization of drug dosage regimen.ppt

    1/34

    K.P. ARUNK.P. ARUNLECTURERLECTURER

    DEPARTMENT OF PHARMACY PRACTICEDEPARTMENT OF PHARMACY PRACTICE

     JSS COLLEGE OF PHARMACY  JSS COLLEGE OF PHARMACY 

    OOTY OOTY 

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    2/34

    INTRODUCTIONINTRODUCTION

    ALL HUMANS ARE ALIKE - True only a a S!e"#eALL HUMANS ARE ALIKE - True only a a S!e"#e

    D#$eren"e e%#& - #n"lu'#n( &)e#r re!on#*eneD#$eren"e e%#& - #n"lu'#n( &)e#r re!on#*ene&o 'ru(&o 'ru(

    T)ere+ore, &)ere # a +reuen& nee' &o &a#lor 'ru(T)ere+ore, &)ere # a +reuen& nee' &o &a#lor 'ru(a'#n#&raon &o &)e #n'#*#'ual !aen&a'#n#&raon &o &)e #n'#*#'ual !aen&

    A +a#lure &o 'o o lea' &o #ne$e"*e &)era!y #nA +a#lure &o 'o o lea' &o #ne$e"*e &)era!y #n

    oe !aen& an' &o%#"#&y #n o&)eroe !aen& an' &o%#"#&y #n o&)er

    T)ere+ore, &)e a#n ")allen(e #n 'e#(n#n( aT)ere+ore, &)e a#n ")allen(e #n 'e#(n#n( a/&an'ar'0 'ru( 'oa(e re(#en # &)e *ar#a1#l#&y/&an'ar'0 'ru( 'oa(e re(#en # &)e *ar#a1#l#&y#n 'ru( )an'l#n( &)a& e%#& +ro !aen& &o !aen#n 'ru( )an'l#n( &)a& e%#& +ro !aen& &o !aen&&

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    3/34

    INTRODUCTION2INTRODUCTION2Un'er&an'#n( &)e our"e o+ &)# *ar#a1#l#&y an'Un'er&an'#n( &)e our"e o+ &)# *ar#a1#l#&y an'a'3un( 'ru( 'oe a""or'#n(ly # an area #na'3un( 'ru( 'oe a""or'#n(ly # an area #n

    4)#") !)ara"#& "an a5e a a3or #!a"& on4)#") !)ara"#& "an a5e a a3or #!a"& onr#5 ana(een& an' !aen& "arer#5 ana(een& an' !aen& "are

    A*era(e 'a&a are ue+ul a a (u#'e6 1u&A*era(e 'a&a are ue+ul a a (u#'e6 1u&

    ula&ely, #n+oraon !er&a#n#n( &o &)eula&ely, #n+oraon !er&a#n#n( &o &)e#n'#*#'ual !aen& # all-#!or&an& 7#n'#*#'ual !aen& # all-#!or&an& 7 interindividualinterindividualvariability variability 

    In&ra#n'#*#'ual *ar#a1#l#&yIn&ra#n'#*#'ual *ar#a1#l#&y # (enerally u")# (enerally u")

    aller &)an #n&er#n'#*#'ual *ar#a1#l#&yaller &)an #n&er#n'#*#'ual *ar#a1#l#&y

    T)ere are &)ree a#n our"e o+ *ar#a1#l#&y #nT)ere are &)ree a#n our"e o+ *ar#a1#l#&y #n!)ara"o5#ne" o+ 'ru( an' "oneuen&ly!)ara"o5#ne" o+ 'ru( an' "oneuen&ly

    !aen&0 re!one &o 'ru(!aen&0 re!one &o 'ru(

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    4/34

    INTRODUCTION...INTRODUCTION...

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    5/34

    8IOLOGICAL FACTORS8IOLOGICAL FACTORS9. A(e:9. A(e:T)e +a"&or &)a& a$e"& 'ru( a1or!on,T)e +a"&or &)a& a$e"& 'ru( a1or!on,

    #n"lu'#n( (a&r#" !H, (a&r#" e!&y#n(, #n&enal#n"lu'#n( (a&r#" !H, (a&r#" e!&y#n(, #n&enal

    ol#&y , an' 1loo' ;o4 ")an(e 4#&) a(eol#&y , an' 1loo' ;o4 ")an(e 4#&) a(e

    T)u, #n &)e neona&e a "on'#on o+ a")lor)y'r#aT)u, #n &)e neona&e a "on'#on o+ a")lor)y'r#a

    !er#& +or &)e

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    6/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS29. A(e29. A(e2

    S5ele&al u"le a # alo u") re'u"e', an'S5ele&al u"le a # alo u") re'u"e', an'u"le "on&ra"on, 4)#") &en' &o !roo&e 1o&)u"le "on&ra"on, 4)#") &en' &o !roo&e 1o&)1loo' ;o4 an' !rea'#n( o+ an #n&rau"ularly1loo' ;o4 an' !rea'#n( o+ an #n&rau"ularlya'#n#&ere' 'ru(, are rela*ely +ee1lea'#n#&ere' 'ru(, are rela*ely +ee1le

    An ele*a&e' (a&r#" !H, a 'elay #n (a&r#"An ele*a&e' (a&r#" !H, a 'elay #n (a&r#"e!&y#n(, an' 1o&) '##n#)e' #n&enal ol#&ye!&y#n(, an' 1o&) '##n#)e' #n&enal ol#&yan' 1loo' ;o4 are alo een #n &)e el'erlyan' 1loo' ;o4 are alo een #n &)e el'erly

    D#$eren"e #n 'ru( a1or!on aon( a'ul&, &)eD#$eren"e #n 'ru( a1or!on aon( a'ul&, &)e*ery youn( an' &)e el'erly, are &)ere+ore e%!e"&e'*ery youn( an' &)e el'erly, are &)ere+ore e%!e"&e'

    Generally, ")an(e #n ra&e ra&)er &)an #n e%&en&Generally, ")an(e #n ra&e ra&)er &)an #n e%&en&o+ a1or!on are +oun'o+ a1or!on are +oun'

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    7/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS29. A(e29. A(e2

    T)ee ")an(e &en' &o 1e le a!!aren& #n &)eT)ee ")an(e &en' &o 1e le a!!aren& #n &)eel'erly &)an #n &)e *ery youn(el'erly &)an #n &)e *ery youn(

    C)#l'ren o+&en a!!ear &o a1or1 'ru( aC)#l'ren o+&en a!!ear &o a1or1 'ru( a

    "o!le&ely an', #+ any&)#n(, ore ra!#'ly &)an"o!le&ely an', #+ any&)#n(, ore ra!#'ly &)ana'ul&a'ul&

    A""or'#n(ly, #n u1euen& "al"ulaon o+ 'oa(e,A""or'#n(ly, #n u1euen& "al"ulaon o+ 'oa(e,

    e%&en& o+ a1or!on # aue' no& &o *ary 4#&) a(ee%&en& o+ a1or!on # aue' no& &o *ary 4#&) a(e

      A a3or e%"e!on # +or oe

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    8/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS29. A(e29. A(e2Generally, !laa 1#n'#n( # lo4er #n neona&e &)anGenerally, !laa 1#n'#n( # lo4er #n neona&e &)ana'ul&a'ul&

    Dur#n( a'ul&)oo' &)e *alue o+Dur#n( a'ul&)oo' &)e *alue o+ f f uu >+ra"on o+ un1oun'>+ra"on o+ un1oun''ru( #n !laa? rea#n un")an(e' or &en' &o ra#e +or'ru( #n !laa? rea#n un")an(e' or &en' &o ra#e +or&)oe 'ru( 1oun' &o al1u#n, &)e "on"en&raon o+&)oe 'ru( 1oun' &o al1u#n, &)e "on"en&raon o+4)#") +all l#()&ly 4#&) a'*an"#n( year4)#") +all l#()&ly 4#&) a'*an"#n( year

    T)e ")an(e #n 1#n'#n( # (enerally &oo all, &oT)e ")an(e #n 1#n'#n( # (enerally &oo all, &o4arran& any "on#'eraon o+ 'oe a'3u&en&4arran& any "on#'eraon o+ 'oe a'3u&en&

    Clearan"e, #+ noral#@e' +or 1o'y 4e#()&, # 'e!ree'Clearan"e, #+ noral#@e' +or 1o'y 4e#()&, # 'e!ree'

    #n &)e neona&e, 1u& #n"reae ra!#'ly &o rea") a#n &)e neona&e, 1u& #n"reae ra!#'ly &o rea") aa%#u *alue a& on&), 4)en #& # alo& &4#"ea%#u *alue a& on&), 4)en #& # alo& &4#"e&)a& #n &)e a'ul&&)a& #n &)e a'ul& T)ere+ore, 4e#()& 7noral#@e' "learan"e +all 1u& llT)ere+ore, 4e#()& 7noral#@e' "learan"e +all 1u& ll

    rea#n, &)rou()ou& ")#l')oo', "on#'era1ly a1o*e &)erea#n, &)rou()ou& ")#l')oo', "on#'era1ly a1o*e &)ea'ul& *aluea'ul& *alue

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    9/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS29. A(e29. A(e2T)e )al+ l#+e # )or&e& aroun' 9 year o+ a(e6 #& #T)e )al+ l#+e # )or&e& aroun' 9 year o+ a(e6 #& #lon(e& #n 1o&) ne41orn an' el'erly !aen&lon(e& #n 1o&) ne41orn an' el'erly !aen&

    In !rea&ure ne41orn, &)e ur#nary e%"reon # e*enIn !rea&ure ne41orn, &)e ur#nary e%"reon # e*enore 'e!ree' !er 5#lo(ra o+ 1o'y 4e#()& &)an #n +ull-ore 'e!ree' !er 5#lo(ra o+ 1o'y 4e#()& &)an #n +ull-&er neona&e&er neona&e

    Me&a1ol#" a"*#&y ay &a5e on&) &o a&ure, &)e eMe&a1ol#" a"*#&y ay &a5e on&) &o a&ure, &)e ereu#re' +or +ull a&uraon *ar#e 4#&) &)e en@yereu#re' +or +ull a&uraon *ar#e 4#&) &)e en@yey&ey&e

    A 'e"reae #n un1oun' e&a1ol#" "learan"e #n &)eA 'e"reae #n un1oun' e&a1ol#" "learan"e #n &)e

    el'erly !aen& )a 1een 'eon&ra&e' +or an #n"rea#n(el'erly !aen& )a 1een 'eon&ra&e' +or an #n"rea#n(nu1er o+ 'ru(, e!e"#ally, &)oe !r#n"#!ally 1y o%#'aonnu1er o+ 'ru(, e!e"#ally, &)oe !r#n"#!ally 1y o%#'aon T)ee ")an(e ay 1e ao"#a&e' #n !ar&, 4#&) &)eT)ee ")an(e ay 1e ao"#a&e' #n !ar&, 4#&) &)e'e"reae #n &)e #@e o+ &)e l#*er, a a !ro!oron o+ 1o'y'e"reae #n &)e #@e o+ &)e l#*er, a a !ro!oron o+ 1o'y4e#()&, +ro B. #n &)e youn( a'ul& &o 9. a& year4e#()&, +ro B. #n &)e youn( a'ul& &o 9. a& year

    o+ a(eo+ a(e

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    10/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2B. 8o'y e#()&:B. 8o'y e#()&:One a!e"& o+ a(#n( # 1o'y 4e#()&One a!e"& o+ a(#n( # 1o'y 4e#()&

    e#()&, =. 5( a& 1#r&), #n"reae ra!#'ly #n ")#l')oo'e#()&, =. 5( a& 1#r&), #n"reae ra!#'ly #n ")#l')oo'an' a'ole"en"e an' &)en 'e"l#ne lo4ly #n &)e el'erlyan' a'ole"en"e an' &)en 'e"l#ne lo4ly #n &)e el'erly

    A 1o'y 4a&er !a"e, u"le a, or(an 1loo' ;o4,A 1o'y 4a&er !a"e, u"le a, or(an 1loo' ;o4,

    an' or(an +un"on are rela&e' &o 1o'y 4e#()&, &)ean' or(an +un"on are rela&e' &o 1o'y 4e#()&, &)e*olue o+ '#&r#1uon, "learan"e an' )en"e 'oa(e*olue o+ '#&r#1uon, "learan"e an' )en"e 'oa(ere(#en o+ 'ru( alo 'e!en' on 1o'y 4e#()&re(#en o+ 'ru( alo 'e!en' on 1o'y 4e#()&

    Ho4e*er, a 4e#()& a'3u&en& # (enerally &)ou()&Ho4e*er, a 4e#()& a'3u&en& # (enerally &)ou()&

    ne"eary only #+ &)e 4e#()& o+ an #n'#*#'ual '#$er 1yne"eary only #+ &)e 4e#()& o+ an #n'#*#'ual '#$er 1yore &)an = +ro &)e a*era(e a'ul& 4e#()& > 5(?ore &)an = +ro &)e a*era(e a'ul& 4e#()& > 5(?

    In !ra""e, &)en, a'3u&en& +or 4e#()& are a'eIn !ra""e, &)en, a'3u&en& +or 4e#()& are a'eonly +or &)e ")#l' an' +or &)e a'ul& 4)o # all, &)#n,only +or &)e ")#l' an' +or &)e a'ul& 4)o # all, &)#n,

    1#(, or o1ee1#(, or o1ee

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    11/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2B. 8o'y e#()&:B. 8o'y e#()&:

    A 'oe "orre"on u& 1e "on#'ere' +or &)#n an'A 'oe "orre"on u& 1e "on#'ere' +or &)#n an'o1ee !aen&o1ee !aen&

    T)e '#$eren"e #n loa'#n( 'oe ay no& 1e a (rea&T)e '#$eren"e #n loa'#n( 'oe ay no& 1e a (rea&a an"#!a&e' +ro 1o'y 4e#()& alonea an"#!a&e' +ro 1o'y 4e#()& alone

    8e"aue, '#&r#1uon (e& a(e-rela&e' ")an(e an'8e"aue, '#&r#1uon (e& a(e-rela&e' ")an(e an'u") 'e!en' on &)e !)y#"o")e#"al !ro!ere o+u") 'e!en' on &)e !)y#"o")e#"al !ro!ere o+&)e 'ru(&)e 'ru(

    For e%a!le, '#(o%#n an' o&)er !olar 'ru( >4a&erFor e%a!le, '#(o%#n an' o&)er !olar 'ru( >4a&erolu1le? )o4 1e&&er "orrelaon 1e&4een un1oun'olu1le? )o4 1e&&er "orrelaon 1e&4een un1oun'*olue o+ '#&r#1uon >*olue o+ '#&r#1uon >V V uu? 4#&) lean 1o'y a,? 4#&) lean 1o'y a,

    4)#") # ##lar #n o1ee an' a*era(e !eron o+ &)e4)#") # ##lar #n o1ee an' a*era(e !eron o+ &)eae )e#()& an' +rae, &)an 4#&) &o&al 1o'y 4e#()&ae )e#()& an' +rae, &)an 4#&) &o&al 1o'y 4e#()&

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    12/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2B. 8o'y e#()&:B. 8o'y e#()&:

    In "on&ra&, &o&al 1o'y 4e#()& ay 1e oreIn "on&ra&, &o&al 1o'y 4e#()& ay 1e orerele*an& +or a 'ru( &)a& # )#()ly l#!#' olu1lerele*an& +or a 'ru( &)a& # )#()ly l#!#' olu1le

    T)ou() renal an' )e!a" +un"on are rela&e'T)ou() renal an' )e!a" +un"on are rela&e'&o 1o'y #@e, o1e#&y ay no& !ro'u"e a&o 1o'y #@e, o1e#&y ay no& !ro'u"e a"orre!on'#n( #n"reae #n )e!a" +un"on"orre!on'#n( #n"reae #n )e!a" +un"on

    Coneuen&ly, &)e ue o+ &o&al 1o'y 4e#()& &oConeuen&ly, &)e ue o+ &o&al 1o'y 4e#()& &o'e&er#ne a 'ru( 'oa(e re(#en "oul' reul& #n'e&er#ne a 'ru( 'oa(e re(#en "oul' reul& #n

    &o%#" e$e"& #+ &)e !aen& # (roly o1ee&o%#" e$e"& #+ &)e !aen& # (roly o1ee

    T)u, &)ou() any 'ru( 'oe are 1ae' on &)eT)u, &)ou() any 'ru( 'oe are 1ae' on &)e1o'y 4e#()& o+ &)e !aen& >e%!ree' a (5(?,1o'y 4e#()& o+ &)e !aen& >e%!ree' a (5(?,

    &)e #n;uen"e o+ o1e#&y or alnour#)en& # no&&)e #n;uen"e o+ o1e#&y or alnour#)en& # no&al4ay "on#'ere'al4ay "on#'ere'

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    13/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2=. Gen'er:=. Gen'er:

    Gene" an' !)y#olo(#"al '#$eren"e 1e&4een enGene" an' !)y#olo(#"al '#$eren"e 1e&4een enan' 4oen "an #n;uen"e 1o&) PK an' PDan' 4oen "an #n;uen"e 1o&) PK an' PD

    For e%a!le, any (ene on &)e Y ")roooe,For e%a!le, any (ene on &)e Y ")roooe,4)#") are e%!ree' only #n ale, )a*e no4)#") are e%!ree' only #n ale, )a*e no

    "oun&er!ar& on &)e ")roooe"oun&er!ar& on &)e ")roooe

    T)e Y ")roooe )a (ene #n*ol*e' #n 1a#"T)e Y ")roooe )a (ene #n*ol*e' #n 1a#""ellular +un"on an' oe (ene on &)e "ellular +un"on an' oe (ene on &)e

    ")roooe are e%!ree' a& )#()er le*el #n +eale")roooe are e%!ree' a& )#()er le*el #n +eale

    Gene e%!re#on an' re(ulaon are l#5ely &o 1eGene e%!re#on an' re(ulaon are l#5ely &o 1e#n;uen"e' 1y )oronal '#$eren"e 1e&4een ale#n;uen"e' 1y )oronal '#$eren"e 1e&4een alean' +ealean' +eale

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    14/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2=. Gen'er2=. Gen'er2

    Geno#" #!r#nn(, 1o'y #@e, or(an #@e, 1o'yGeno#" #!r#nn(, 1o'y #@e, or(an #@e, 1o'y+a&, ADME "an alo a$e"& !)ara"olo(#"al ou&"oe+a&, ADME "an alo a$e"& !)ara"olo(#"al ou&"oe

    O&)er +a"&or u") a (a&ro#n&enal &ran#& e,O&)er +a"&or u") a (a&ro#n&enal &ran#& e,l#*er en@ye +un"on an' ur#nary "rean#nel#*er en@ye +un"on an' ur#nary "rean#ne"learan"e are #n;uen"e' 1y 1o&) a(e an' e%"learan"e are #n;uen"e' 1y 1o&) a(e an' e%

    A"ro &)e !a&) o+ a 4oan0 l#+e #& # ne"eary &oA"ro &)e !a&) o+ a 4oan0 l#+e #& # ne"eary &o"on#'er &)e &a(e o+ o*ar#an +un"on &o a!!re"#a&e"on#'er &)e &a(e o+ o*ar#an +un"on &o a!!re"#a&e

    &)e !o&enal +or 'ru(, e%, an' a(e #n&era"on a&)e !o&enal +or 'ru(, e%, an' a(e #n&era"on a&)ey #n;uen"e raonal 'ru( &)era!y&)ey #n;uen"e raonal 'ru( &)era!y

    Ue o+ oral "on&ra"e!*e an' )oronal ")an(eUe o+ oral "on&ra"e!*e an' )oronal ")an(e

    4)#") o""ur &)rou()ou& &)e en&rual "y"le4)#") o""ur &)rou()ou& &)e en&rual "y"le#n;uen"e !)ara"olo(#"al reul&#n;uen"e !)ara"olo(#"al reul&

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    15/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2=. Gen'er2=. Gen'er2Ne"eary "on#'eraon 'ur#n( !re(nan"y areNe"eary "on#'eraon 'ur#n( !re(nan"y areal&eraon #n 1o'y "o!o#on, "ar'#a" ou&!u&,al&eraon #n 1o'y "o!o#on, "ar'#a" ou&!u&,

    !ulonary an' renal +un"on a 4ell a ")an(e #n!ulonary an' renal +un"on a 4ell a ")an(e #n#une an' (a&ro#n&enal y&e#une an' (a&ro#n&enal y&e

    In eno!aue, &)e o*ar#e, u&eru, ur#nary &ra"&,In eno!aue, &)e o*ar#e, u&eru, ur#nary &ra"&,)y!o&)alau, "ar'#o*a"ular y&e, an' l#*er are)y!o&)alau, "ar'#o*a"ular y&e, an' l#*er are

    oe o+ &)e ue, or(an or y&e 4)#") areoe o+ &)e ue, or(an or y&e 4)#") areal&ere' 1y &)e lo o+ e&ro(en, an'ro(en, an'al&ere' 1y &)e lo o+ e&ro(en, an'ro(en, an'!ro(e&a(en!ro(e&a(en

    T)ee )oronal ")an(e are alo ao"#a&e' 4#&) &)eT)ee )oronal ")an(e are alo ao"#a&e' 4#&) &)ee%!re#on o+ '#$eren& '#eae a+&er eno!auee%!re#on o+ '#$eren& '#eae a+&er eno!aue

    Se% '#$eren"e #n"lu'e &)e o1er*aon &)a& #n anySe% '#$eren"e #n"lu'e &)e o1er*aon &)a& #n any'e*elo!e' "oun&r#e 4oen &a5e ore e'#"aon,'e*elo!e' "oun&r#e 4oen &a5e ore e'#"aon,"rean( &)e !o&enal +or a'*ere e$e"& 1ae' on 'ru("rean( &)e !o&enal +or a'*ere e$e"& 1ae' on 'ru(#n&era"on, &)ey a!!ear ore en#*e &o a'*ere#n&era"on, &)ey a!!ear ore en#*e &o a'*ere

    e*en&, an' ay 1e o*er'oe' ore +reuen&lye*en&, an' ay 1e o*er'oe' ore +reuen&ly

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    16/34

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    17/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2=. Gen'er2=. Gen'er2

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    18/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2=. Gen'er2=. Gen'er2

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    19/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2=. Gen'er2=. Gen'er2

    Buserelin for endometriosis (300 µg intra nasally 3times

    a day) or for prostate cancer (200µg intra nasally 6

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    20/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2. Gene":. Gene":Gene" !olyor!)# &)a& lea' &o &)e !ro'u"on o+Gene" !olyor!)# &)a& lea' &o &)e !ro'u"on o+

    #oen@ye 4#&)#oen@ye 4#&) re'u"e're'u"e'  oror no a"*#&y o+no a"*#&y o+ &o&o ul!leul!le"o!#e o+"o!#e o+ an en@ye 4#&)an en@ye 4#&) )#() a"*#&y)#() a"*#&y a5e a a3ora5e a a3or"on&r#1uon &o &)e *ar#a1#l#&y #n &)e 'oe reu#reen&"on&r#1uon &o &)e *ar#a1#l#&y #n &)e 'oe reu#reen&o+ 'ru( &)a& el##na&e' 1y )e!a" e&a1ol#o+ 'ru( &)a& el##na&e' 1y )e!a" e&a1ol#

    Cy&o")roe P >CYP ? en@ye, P 7Cy&o")roe P >CYP ? en@ye, P 7(ly"o!ro&e#n are #n"rea#n(ly 1e#n( re"o(n#@e' +or(ly"o!ro&e#n are #n"rea#n(ly 1e#n( re"o(n#@e' +or&)e#r #!or&an"e &o !)ara"o5#ne" *ar#a1#l#&y&)e#r #!or&an"e &o !)ara"o5#ne" *ar#a1#l#&y

    Mo& o+ &)ee (ene" '#$eren"e are "o!le% an' areMo& o+ &)ee (ene" '#$eren"e are "o!le% an' are'#"ul& &o 'e&er#ne 4#&) any 'e(ree o+ "er&a#n&y6 1u&'#"ul& &o 'e&er#ne 4#&) any 'e(ree o+ "er&a#n&y6 1u&

    a +e4 (ene" '#$eren"e are 4ell 'o"uen&e'a +e4 (ene" '#$eren"e are 4ell 'o"uen&e'>o%#'aon, S- e&)ylaon, an' a"e&ylaon?>o%#'aon, S- e&)ylaon, an' a"e&ylaon?

    In +u&ure, (ene" "reen#n( >!)eno&y!#n(? ay 1eIn +u&ure, (ene" "reen#n( >!)eno&y!#n(? ay 1e'one &o #n'#*#'ual !aen& &o 'e#(n &)e 'oe o+ a'one &o #n'#*#'ual !aen& &o 'e#(n &)e 'oe o+ a

    'ru('ru(

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    21/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2. Gene"2. Gene"2

    Probe drugs approved by US !" for geneticp#enotyping

    $mepra%ole & Pantopra%ole (P#enotyping for'P2'*)

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    22/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2. Gene"2. Gene"2

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    23/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2. D#eae Con'#on:. D#eae Con'#on:

    D#eae # a a3or our"e o+ *ar#a1#l#&y #n 'ru(D#eae # a a3or our"e o+ *ar#a1#l#&y #n 'ru(re!onere!one

    T)e PK an' PD o+ oe 'ru( )a*e 1een )o4nT)e PK an' PD o+ oe 'ru( )a*e 1een )o4n

    &o 1e #n;uen"e' 1y &)e !reen"e o+ "on"urren&&o 1e #n;uen"e' 1y &)e !reen"e o+ "on"urren&'#eae o&)er &)an &)e one +or 4)#") a 'ru( #'#eae o&)er &)an &)e one +or 4)#") a 'ru( #ue'ue'

    T)ere are alo o""a#on 4)en &)eT)ere are alo o""a#on 4)en &)e

    !)ara"o5#ne" o+ a 'ru( # al&ere' #n &)e!)ara"o5#ne" o+ a 'ru( # al&ere' #n &)e'#eae +or 4)#") #& # ue''#eae +or 4)#") #& # ue'

    D#eae o+ &)e 5#'ney, l#*er, "ar'#o *a"ularD#eae o+ &)e 5#'ney, l#*er, "ar'#o *a"ulary&e, re!#ra&ory y&e, (a&ro#n&enaly&e, re!#ra&ory y&e, (a&ro#n&enal

    y&e an' en'o"r#ne y&e are &)e a3ory&e an' en'o"r#ne y&e are &)e a3or"aue &)a& 4arran& #n'#*#'ual#@e' 'ru( &)era!y"aue &)a& 4arran& #n'#*#'ual#@e' 'ru( &)era!y

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    24/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2. D#eae Con'#on2. D#eae Con'#on2CONDITIO

    N

    DRUG O8SERATIO

    N

    ARIATION

    IN

    COMMENTS

    PK PD

    HEPATIC DISEASES

    C#rr)o# T)eo!)yll#n

    e

    Slo4er +all #n

    !laa"on"en&raon

    - Clearan"ere'u"e'.Re'u"e &)e'oa(e &oa*o#' &o%#"#&y

    A"u&e *#ral)e!a

    ar+ar#n E%"e#*ean"oa(ulan&

    re!one

    - Re'u"e'oa(e &o

    leen r#5 o+)eorr)a(e

    RENAL DISEASES

    Ure#a Gen&ay"#n In"reae'&o%#"#&y 4#&)uual 'oa(e

    - Renal"learan"e'##n#)e'6

    re'u"e'oa(e &o

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    25/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2. D#eae Con'#on2. D#eae Con'#on2CONDITIO

    N

    DRUG O8SERATIO

    N

    ARIATION

    IN

    COMMENTS

    PK PD

    CARDIOASCULAR DISEASE

    Con(e*e

    Car'#a"Fa#lure

    l#'o"a#ne Ele*a&e'

    !laa"on"en&raona+&er uual'oa(e

    - Clearan"e an'

    ' re'u"e'.Re'u"e &)e'oa(e &oleen&o%#"#&y

    GASTROINTESTINAL DISEASES

    Cel#a"D#eae

    Fu#'#" A"#' Ele*a&e'!laa"on"en&raona+&er uual'oa(e

    - 8A #n"reae'an' Clearan"e'##n#)e'

    Cro)n0

    D#eae

    Pro!ranolol Ele*a&e'

    !laa"on"en&raon

    NS In"reae'

    !laa1#n'#n(,

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    26/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2. D#eae Con'#on2. D#eae Con'#on2

    CONDITION

    DRUG O8SERATION

    ARIATIONIN

    COMMENTS

    PK PD

    RESPIRATORY DISEASES

    A&)a Tol1u&a#'e

    More ra!#' +all#n !laa"on"en&raon

    - T)era!eu""oneuen"eun"er&a#n

    E!)yea Mor!)#ne In"reae'en#*#&y &ore!#ra&ory'e!rean&e$e"&

    NS NS Re'u"e 'oe&o '##n#)r#5 o+re!#ra&ory"o!l#"aon

    Cy"

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    27/34

    8IOLOGICAL FACTORS28IOLOGICAL FACTORS2. D#eae Con'#on2. D#eae Con'#on2CONDITIO

    N

    DRUG O8SERATION ARIATION

    IN

    COMMENTS

    PK PD

    ENDOCRINE DISEASE

    T)yro#'

    '#eae

    D#(o%#n D##n#)e'

    re!one #n )y!er&)yro#'#6#n"reae're!one #ny%e'ea

    - A'3u& 'oa(ea""or'#n( &o&)yro#'a"*#&y

    OTHER

    Fe*er u#n#ne Plaa"on"en&raon o+'ru( ele*a&e', o+e&a1ol#&e'e!ree', a+&eruual 'oa(e

    NS I!a#re'e&a1ol#u!e"&e'6ay nee' &ore'u"e 'oe#n e*ere+e1r#le &a&e

    . /stablis#ed source of ariability-. 1o evidence t#at variability is increased due to

    disease1S 1ot Studied

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    28/34

    ENIRONMENTAL FACTORSENIRONMENTAL FACTORS9. Dru( In&era"on:9. Dru( In&era"on:

    Many o+ &)e "l#n#"ally #(n#

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    29/34

    ENIRONMENTAL FACTORSENIRONMENTAL FACTORS9. Dru( In&era"on29. Dru( In&era"on2

    A1or!on:A1or!on:

    S&u'#e )a*e 'eon&ra&e' &)e #!or&an"e o+S&u'#e )a*e 'eon&ra&e' &)e #!or&an"e o+#n&enal CYP=A an' P 7 (ly"o!ro&e#n #n 'ru(#n&enal CYP=A an' P 7 (ly"o!ro&e#n #n 'ru(

    a1or!ona1or!on

    In'u"on o+ &)ee e")an# 1y r#+a!#"#nIn'u"on o+ &)ee e")an# 1y r#+a!#"#nan' 1y S& Jo)n0 4or& )a*e 1een )o4n &oan' 1y S& Jo)n0 4or& )a*e 1een )o4n &ore'u"e &)e 8A o+ D#(o%#nre'u"e &)e 8A o+ D#(o%#n

    A1or!on "an alo 1e al&ere' 1y 'ru(A1or!on "an alo 1e al&ere' 1y 'ru(#n&era"on 4#&)#n &)e (u& &)a& reul& +ro#n&era"on 4#&)#n &)e (u& &)a& reul& +ro1#n'#n( &o o&)er 'ru(, u") a ")ole&yra#ne1#n'#n( &o o&)er 'ru(, u") a ")ole&yra#neor an&a"#', or &o en&eral +ee', a #n &)e "ae o+or an&a"#', or &o en&eral +ee', a #n &)e "ae o+

    P)eny&o#nP)eny&o#n

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    30/34

    ENIRONMENTAL FACTORSENIRONMENTAL FACTORS9. Dru( In&era"on29. Dru( In&era"on2

    D#&r#1uon:D#&r#1uon:Dru( '#&r#1uon "an 1e al&ere' 1y #n&era"onDru( '#&r#1uon "an 1e al&ere' 1y #n&era"on&)a& "aue '#!la"een& +ro !laa !ro&e#n&)a& "aue '#!la"een& +ro !laa !ro&e#n1#n'#n(1#n'#n(

    8u&, &)ee 'o no& norally al&er a#n&enan"e8u&, &)ee 'o no& norally al&er a#n&enan"e'oe reu#reen& unle &)ere # alo a re'u"on'oe reu#reen& unle &)ere # alo a re'u"on#n &)e "learan"e o+ un1oun' 'ru(#n &)e "learan"e o+ un1oun' 'ru(

    Me&a1ol#:Me&a1ol#:Me&a1ol# "an 1e al&ere' 1y en@ye #n'u"onMe&a1ol# "an 1e al&ere' 1y en@ye #n'u"onor #n)#1#onor #n)#1#on

    Due &o 4#'e *ar#a1#l#&y #n en@ye a"*#&y, &)eDue &o 4#'e *ar#a1#l#&y #n en@ye a"*#&y, &)e

    "l#n#"al #(n#

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    31/34

    ENIRONMENTAL FACTORSENIRONMENTAL FACTORS9. Dru( In&era"on29. Dru( In&era"on2Me&a1ol#2Me&a1ol#2T)ee #n&era"on are o+&en 'oe-'e!en'en& an'T)ee #n&era"on are o+&en 'oe-'e!en'en& an'&)e e"ale o+ &)e o$e& an' one& o+ &)e e$e"&&)e e"ale o+ &)e o$e& an' one& o+ &)e e$e"&'e!en' no& only on &)e PK o+ &4o >or ore? 'ru('e!en' no& only on &)e PK o+ &4o >or ore? 'ru("on"erne', 1u& alo &)e #oen@ye>? re!on#1le +or"on"erne', 1u& alo &)e #oen@ye>? re!on#1le +or&)e#r e&a1ol#&)e#r e&a1ol#

    E%"reon:E%"reon:Pro1ene"#' re'u"e &)e renal e%"reon o+ anyPro1ene"#' re'u"e &)e renal e%"reon o+ anyan#o" 1y "o!en( +or an#on e"reonan#o" 1y "o!en( +or an#on e"reon&ran!or& e")an#&ran!or& e")an#

    C)an(e #n 1#l#ary e"reon an' en&ero-)e!a"C)an(e #n 1#l#ary e"reon an' en&ero-)e!a""#r"ulaon "an alo !lay a role"#r"ulaon "an alo !lay a role

    For e%a!le, Pen#"#ll#n "an #!a#r &)e re"#r"ulaonFor e%a!le, Pen#"#ll#n "an #!a#r &)e re"#r"ulaon

    o+ oral "on&ra"e!*e 1y al&er#n( &)e 1a"&er#al ;orao+ oral "on&ra"e!*e 1y al&er#n( &)e 1a"&er#al ;orao+ &)e (u&o+ &)e (u&

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    32/34

    ENIRONMENTAL FACTORSENIRONMENTAL FACTORSB. O&)er En*#ronen&al Fa"&or:B. O&)er En*#ronen&al Fa"&or:D#e&, "l#a&e, o5#n(, al"o)ol, 'ru(, !ollu&an&D#e&, "l#a&e, o5#n(, al"o)ol, 'ru(, !ollu&an&ay "aue 4#'e *ar#aon #n 'ru( re!one 4#&)#nay "aue 4#'e *ar#aon #n 'ru( re!one 4#&)#nan #n'#*#'ualan #n'#*#'ual

    Se*eral o+ &)ee +a"&or "an o!era&eSe*eral o+ &)ee +a"&or "an o!era&e#ul&aneouly #n &)e ae #n'#*#'ual, &)u#ul&aneouly #n &)e ae #n'#*#'ual, &)u

    a$e"n( &)e !ro"ee o+ ADME an' re"e!&ora$e"n( &)e !ro"ee o+ ADME an' re"e!&or#n&era"on #n '#$eren& 4ay an' &o '#$erenn&era"on #n '#$eren& 4ay an' &o '#$eren&'e(ree'e(ree

    S&u'#e "o!ar#n( &)e e&a1ol# o+ An!yr#neS&u'#e "o!ar#n( &)e e&a1ol# o+ An!yr#ne

    1e&4een A#an In'#an #n rural In'#an *#lla(e an'1e&4een A#an In'#an #n rural In'#an *#lla(e an'In'#an ##(ran& #n En(lan' 'eon&ra&e' &)a& aIn'#an ##(ran& #n En(lan' 'eon&ra&e' &)a& a##(ran& a'o!&e' &)e l#+e&yle an' '#e&ary )a1#&##(ran& a'o!&e' &)e l#+e&yle an' '#e&ary )a1#&o+ &)e 8r#), &)e#r 'ru( e&a1ol# a""elera&e'o+ &)e 8r#), &)e#r 'ru( e&a1ol# a""elera&e'

    L#()&-5#nne' #n'#*#'ual are u13e"& &o 'ru(-L#()&-5#nne' #n'#*#'ual are u13e"& &o 'ru(-#n'u"e' !)o&o&o%#"#&y a+&er #n(en( "er&a#n 'ru(#n'u"e' !)o&o&o%#"#&y a+&er #n(en( "er&a#n 'ru(

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    33/34

    CULTURAL FACTORSCULTURAL FACTORS

    Cul&ural or !y")oo"#al +a"&or, u") a &)eCul&ural or !y")oo"#al +a"&or, u") a &)e

    a&&u'e an' 1el#e+ o+ an e&)n#" (rou!, aya&&u'e an' 1el#e+ o+ an e&)n#" (rou!, aya$e"& &)e e$e"*ene o+, or a')eren"e &o, aa$e"& &)e e$e"*ene o+, or a')eren"e &o, a!ar"ular 'ru( &)era!y!ar"ular 'ru( &)era!y

    S&u'#e )a*e "on#&en&ly )o4n &)a& A+r#"an-S&u'#e )a*e "on#&en&ly )o4n &)a& A+r#"an-Aer#"an !aen& are ore l#5ely &o 1e o*erAer#"an !aen& are ore l#5ely &o 1e o*er'#a(noe' a )a*#n( a !y")o" #llne an' are'#a(noe' a )a*#n( a !y")o" #llne an' areore l#5ely &o 1e &rea&e' 4#&) neurole!"ore l#5ely &o 1e &rea&e' 4#&) neurole!"re(ar'le o+ '#a(no#re(ar'le o+ '#a(no#

    A+r#"an-Aer#"an are alo ore l#5ely &o 1eA+r#"an-Aer#"an are alo ore l#5ely &o 1e!la"e' on #!lan&e' or !er#o'#"ally #n3e"&e'!la"e' on #!lan&e' or !er#o'#"ally #n3e"&e'ra&)er &)an oral e'#"aon, re;e"n(ra&)er &)an oral e'#"aon, re;e"n(!)y#"#an0 "on"ern a1ou& a')eren"e!)y#"#an0 "on"ern a1ou& a')eren"e

  • 8/18/2019 Individualization of drug dosage regimen.ppt

    34/34

    CONCLUSIONSCONCLUSIONS

    Heal&) "are !ro*#'er )oul' (#*e #n'#*#'ual#@e'Heal&) "are !ro*#'er )oul' (#*e #n'#*#'ual#@e'

    &rea&en& &o ea") !aen& an' re#& &)e &e!&aon&rea&en& &o ea") !aen& an' re#& &)e &e!&aon&o a!!ly "oo51oo5Q 'ru( &)era!y &)a& 'oe no& &a5e&o a!!ly "oo51oo5Q 'ru( &)era!y &)a& 'oe no& &a5e#n&o a""oun& *ar#aon aon( #n'#*#'ual !aen&#n&o a""oun& *ar#aon aon( #n'#*#'ual !aen&

    For &)e !ra""#n( !)y#"#an, ea") !aen&For &)e !ra""#n( !)y#"#an, ea") !aen&

    re!reen& a un#ue an' 'yna#" #n&era"on aon(re!reen& a un#ue an' 'yna#" #n&era"on aon('e&er#nan& &)a& are 1o&) (ene" an''e&er#nan& &)a& are 1o&) (ene" an'en*#ronen&alen*#ronen&al

    I& # #!era*e &o #n'#*#'ual#@e &)era!y 4#&)I& # #!era*e &o #n'#*#'ual#@e &)era!y 4#&)re!e"& &o &)e a!!ro!r#a&e ")o#"e o+ 1o&) 'ru( an're!e"& &o &)e a!!ro!r#a&e ")o#"e o+ 1o&) 'ru( an''oe'oe

    A Cl#n#"al !)ara"#& 4#&) a'eua&eA Cl#n#"al !)ara"#& 4#&) a'eua&e!)ara"o5#ne" 1a"5(roun' "an !lay a *#&al role #n!)ara"o5#ne" 1a"5(roun' "an !lay a *#&al role #n)el!#n( &)e !)y#"#an +or #n'#*#'ual#@#n( 'ru()el!#n( &)e !)y#"#an +or #n'#*#'ual#@#n( 'ru(

    &)era!y&)era!y